News & Updates
Filter by Specialty:
Lenalidomide plus R-CHOP effective for untreated DLBCL patients
16 Oct 2021
Combining lenalidomide with R-CHOP* (R2CHOP) yields durable and high rates of treatment response in untreated patient with diffuse large B-cell lymphoma (DLBCL), a recent study has found.
Lenalidomide plus R-CHOP effective for untreated DLBCL patients
16 Oct 2021Diabetes, hypertension up risk of stroke
16 Oct 2021
Hypertension and diabetes are the major predictors of stroke that must be controlled and treated like other global high-risk populations for stroke prevention, according to a prospective study in India.
Diabetes, hypertension up risk of stroke
16 Oct 2021Marine n-3 PUFAs do not affect incident PAD risk
16 Oct 2021
Higher intake of marine n-3 polyunsaturated fatty acids (PUFAs) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) exerts no significant protective effect against incident peripheral artery disease (PAD), a recent study has found.